SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 15-12B - Securities registration termination [Section 12(b)]:
SEC Accession No. 0001193125-22-166727
Filing Date
2022-06-03
Accepted
2022-06-03 08:00:51
Documents
1
Effectiveness Date
2022-06-03

Document Format Files

Seq Description Document Type Size
1 15-12B d368239d1512b.htm 15-12B 9480
  Complete submission text file 0001193125-22-166727.txt   10792
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 15-12B | Act: 34 | File No.: 001-32302 | Film No.: 22992926
SIC: 3841 Surgical & Medical Instruments & Apparatus
Industrial Applications and Services